Literature DB >> 8543944

A follow-up study on spastic paraparesis in Japanese HAM/TSP.

Y Kuroda1, M Yukitake, K Kurohara, H Takashima, M Matsui.   

Abstract

We followed 24 patients with HTLV-I-associated myelopathy (HAM) for 4-12 years (mean 7 years) and assessed longitudinal changes of their spastic paraparesis by Kurtzke's Disability Status Scale (DSS). The DSS score of spastic paraparesis was unchanged in 18 patients (75%), advanced (worsened) by two in 1 patient and by one in 3 patients, and declined (improved) by one in 2 patients during the follow-up period. The results demonstrated that HAM presents with a variety of clinical courses including spontaneous improvement.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8543944     DOI： 10.1016/0022-510x(95)00142-o

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


  2 in total

Review 1.  HTLV-1 and HIV infections of the central nervous system in tropical areas.

Authors:  P Cabre; D Smadja; A Cabié; C R Newton
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-05       Impact factor: 10.154

2.  Efficacy of Corticosteroid Therapy for HTLV-1-Associated Myelopathy: A Randomized Controlled Trial (HAMLET-P).

Authors:  Junji Yamauchi; Kenichiro Tanabe; Tomoo Sato; Masanori Nakagawa; Eiji Matsuura; Yoshio Tsuboi; Keiko Tamaki; Hirokuni Sakima; Satoshi Ishihara; Yuki Ohta; Naoki Matsumoto; Kenichi Kono; Naoko Yagishita; Natsumi Araya; Katsunori Takahashi; Yasuo Kunitomo; Misako Nagasaka; Ariella Coler-Reilly; Yasuhiro Hasegawa; Abelardo Araujo; Steven Jacobson; Maria Fernanda Rios Grassi; Bernardo Galvão-Castro; Martin Bland; Graham P Taylor; Fabiola Martin; Yoshihisa Yamano
Journal:  Viruses       Date:  2022-01-12       Impact factor: 5.048
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.